Tuesday, BioStar Capital announced that Amplitude Vascular Systems, Inc., a medical technology company, has been acquired by Stryker Corporation (SYK) at a purchase price of up to $835 million.
Amplitude Vascular Systems, which developed a next-generation hydraulic intravascular lithotripsy platform to treat calcified peripheral arterial disease, made the exit before getting FDA approval.
Stryker stated that the acquisition marked an important step in growing its vascular treatment business. Also, it plans to expand the Pulse System, a new treatment option that may work better than current methods using electric balloons or lasers, to help more patients.
In the pre-market hours, SYK is trading at $313.76, up 0.17 percent on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.